Kepler Capital Markets set a €119.00 ($141.67) price objective on Merck KGaA (FRA:MRK) in a research note released on Thursday, September 21st. The firm currently has a buy rating on the healthcare company’s stock.
Several other analysts have also commented on the stock. Berenberg Bank set a €116.00 ($138.10) target price on shares of Merck KGaA and gave the company a buy rating in a research note on Tuesday, September 19th. Goldman Sachs Group, Inc. (The) set a €105.00 ($125.00) price target on shares of Merck KGaA and gave the company a neutral rating in a research report on Tuesday, September 19th. Citigroup Inc. set a €123.00 ($146.43) price target on shares of Merck KGaA and gave the company a buy rating in a research report on Wednesday, September 13th. J P Morgan Chase & Co restated a neutral rating on shares of Merck KGaA in a research report on Wednesday, September 6th. Finally, Commerzbank Ag set a €109.00 ($129.76) price target on shares of Merck KGaA and gave the company a neutral rating in a research report on Wednesday, September 6th. Thirteen investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The stock has an average rating of Hold and a consensus price target of €109.61 ($130.49).
Shares of Merck KGaA (FRA:MRK) traded down 3.29% on Thursday, reaching €94.55. The company had a trading volume of 7,249 shares. The firm has a market capitalization of €41.11 billion and a PE ratio of 24.65. The firm’s 50 day moving average is €93.46 and its 200 day moving average is €102.32. Merck KGaA has a 12 month low of €89.00 and a 12 month high of €115.00.
COPYRIGHT VIOLATION WARNING: This article was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international trademark and copyright law. The legal version of this article can be read at https://www.dispatchtribunal.com/2017/09/29/merck-kgaa-mrk-given-a-119-00-price-target-by-kepler-capital-markets-analysts.html.
Merck KGaA Company Profile
Receive News & Ratings for Merck KGaA Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Merck KGaA and related companies with MarketBeat.com’s FREE daily email newsletter.